← Back to Clinical Trials
Recruiting NCT06735092

NCT06735092 Exercise Therapy and Orthoses in Lateral Elbow Tendinopathy: Comparative Effects

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06735092
Status Recruiting
Phase
Sponsor Istanbul University - Cerrahpasa
Condition Lateral Epicondylitis
Study Type INTERVENTIONAL
Enrollment 45 participants
Start Date 2024-12-02
Primary Completion 2025-08-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Exercise-Only Group (Control Group)Exercise + Forearm Counterforce Brace GroupExercise + Wrist Brace Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 45 participants in total. It began in 2024-12-02 with a primary completion date of 2025-08-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to address the inconsistencies in the literature by investigating the effects of a forearm counterforce brace and a wrist splint, used in addition to exercise therapy, on pain, functionality, and grip strength in individuals diagnosed with lateral elbow tendinopathy, compared to those receiving exercise therapy alone.The findings aim to provide valuable insights into clinical practice by highlighting the roles of both orthosis use and exercise in the treatment of lateral elbow tendinopathy.

Eligibility Criteria

Inclusion Criteria: * Being between the ages of 18 and 65, * Having a diagnosis of unilateral lateral elbow tendinopathy, * Having at least two of the Thomsen, Maudley's, Mill's, or Cozen's tests positive during clinical examination, * Experiencing symptoms for at least 3 months, * Not having a systemic or chronic illness that would prevent participation in the treatment program. Exclusion Criteria: * A history of trauma or surgery in the relevant elbow and/or wrist, * The presence of orthopedic and/or neurological problems in the cervical spine, shoulder joint, or wrist, * Participation in a physiotherapy and rehabilitation program for lateral elbow tendinopathy within the last 6 months, * Receiving any injections within the last 6 months, * Systemic inflammation.

Contact & Investigator

Central Contact

Büşra Kültür, MSc (c)

✉ busragguler@gmail.com

📞 +905352928772

Principal Investigator

Büşra Kültür, MSc

PRINCIPAL INVESTIGATOR

Istanbul University - Cerrahpasa

Frequently Asked Questions

Who can join the NCT06735092 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Lateral Epicondylitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06735092 currently recruiting?

Yes, NCT06735092 is actively recruiting participants. Contact the research team at busragguler@gmail.com for enrollment information.

Where is the NCT06735092 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06735092 clinical trial?

NCT06735092 is sponsored by Istanbul University - Cerrahpasa. The principal investigator is Büşra Kültür, MSc at Istanbul University - Cerrahpasa. The trial plans to enroll 45 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology